GlassScriptPhysician profile
Aimee S Park
NPI 1265435978
$676.22
in general payments reported to CMS, 2019-2025
16 companies · $51.65 in 2025
The $51.65 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $23.36 · 2023: $301 · 2024: $38.06 · 2025: $51.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $176.36 | 2019-2023 | Repatha |
| Amarin Pharma, INC. | $105.47 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $97.58 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.26 | 2023 | Lifevest |
| Kowa Pharmaceuticals America, INC. | $39.29 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $27.15 | 2025 | Opsumit |
| Edwards Lifesciences Corporation | $26.87 | 2019 | |
| Abbott Laboratories | $24.76 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Esperion Therapeutics, INC. | $21.37 | 2024 | Nexletol |
| Janssen Pharmaceuticals, INC | $17.48 | 2019 | |
| Impulse Dynamics (USA) INC. | $16.38 | 2023 | Optimizer |
| Sanofi-Aventis U.S. LLC | $16.31 | 2019 | |
| Astellas Pharma US INC | $14.08 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.69 | 2023 | Brilinta |
| Pfizer INC. | $12.72 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.